Indegene Limited (NSE:INDGN)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Enterprise Commercial Solutions	15.87B
Enterprise Commercial Solutions Growth	3.82%
Enterprise Medical Solutions	8.03B
Enterprise Medical Solutions Growth	33.57%
Omnichannel Activation	3.48B
Omnichannel Activation Growth	8.96%
Other	1.02B
Other Growth	-27.66%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
United States	19.74B
United States Growth	15.47%
Europe	7.61B
Europe Growth	-4.24%
Rest of the World	675.00M
Rest of the World Growth	7.83%
India	194.00M
India Growth	-13.00%
North America	178.00M
North America Growth	2125.00%